The impact of Polymorphisms of rs689 and rs757110 in Familial Type 2 Diabetes: A Case-Control Study in the Iranian Population

Haghighi, Amin; Javid, Amaneh; Khodadadian, Ali; Vahidi Mehrjardi, Mohammad Yahya

doi:10.18502/ijdo.v17i1.18030

Volume 17, Issue 1 (2-2025) IJDO 2025, 17(1): 19-27 | Back to browse issues page

‎ 10.18502/ijdo.v17i1.18030

Mendeley

Zotero

RefWorks

Haghighi A, Javid A, Khodadadian A, Vahidi Mehrjardi M Y. The impact of Polymorphisms of rs689 and rs757110 in Familial Type 2 Diabetes: A Case-Control Study in the Iranian Population. IJDO 2025; 17 (1) :19-27
URL: http://ijdo.ssu.ac.ir/article-1-931-en.html

The impact of Polymorphisms of rs689 and rs757110 in Familial Type 2 Diabetes: A Case-Control Study in the Iranian Population

Amin Haghighi

, Amaneh Javid

, Ali Khodadadian

, Mohammad Yahya Vahidi Mehrjardi ^*

Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Abstract: (71 Views)

Objective: Understanding the genetic basis of type 2 diabetes mellitus (T2DM) is essential in getting its etiology and designing effective preventive strategies. Evaluation of the association between the gene polymorphisms rs689A/T (INS) and rs757110C/A (ABCC8) and the susceptibility to T2DM within a group of individuals diagnosed with T2DM in Iran.
Materials and Methods: Blood samples were used for DNA extraction (200 with T2DM and 200 healthy controls). The quality and quantity of extracted DNA were assessed via ultraviolet spectrophotometry at 260 nm and 280 nm wavelengths. To identify specific alleles, primer sequences were manually designed using Primer3Plus, and the genotypes of rs689 (A>T) and rs757110 C>A were determined through ARMS-PCR. Statistical analysis was conducted using GraphPad Prism version 8.
Results: For rs689 individuals with the genotype (AA) were found to have a higher likelihood of developing diabetes (P= 0.001). Additionally, the frequency of the A allele was found to be higher in the patient group (0.13) compared to the control group (0.05). For rs757110 individuals with the genotype (CC) were found to have a higher likelihood of developing diabetes (P< 0.001). Additionally, the frequency of the C allele was found to be higher in the patient group (0.57) compared to the control group (0.39).
Conclusion: This study found that the frequency of AA and AT genotypes of rs689 and CC and CA genotypes of rs757110 are associated with T2DM risk.

Keywords: Diabetes, ARMS-PCR, rs689, rs757110

Full-Text [PDF 688 kb] (43 Downloads)

Type of Study: Research | Subject: Special
Received: 2024/12/26 | Accepted: 2025/01/29 | Published: 2025/02/27

References

1. Hazar N, Jokar M, Namavari N, Hosseini S, Rahmanian V. An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996-2023. Frontiers in public health. 2024;12:1322072. [DOI:10.3389/fpubh.2024.1322072]

2. Ghadiri-Anar A, Kheirollahi K, Hazar N, Namiranian N, Akhondi-Meybody M, Mayani MA. Frequency of Oral Manifestation in Diabetic Patients in Yazd 2016-2017. Iranian journal of diabetes and obesity. 2020, 12(2): 63-8. [DOI:10.18502/ijdo.v12i2.4043]

3. Perreault L, Skyler JS, Rosenstock J. Novel therapies with precision mechanisms for type 2 diabetes mellitus. Nature Reviews Endocrinology. 2021;17(6):364-77. [DOI:10.1038/s41574-021-00489-y]

4. Sefid F, Monshizadeh K, Azamirad G, Mehrjardi MY. Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy. Iranian journal of diabetes and obesity.2024, 16(2):112-121. [DOI:10.18502/ijdo.v16i2.15710]

5. Sefid F, Azamirad G, Asadollahi S, Kalantar SM, Khalilzade SH, Mehrjardi MY. Common Polymorphisms Identified In Patients with Type 2 Diabetes Mellitus Revealed From Next-Generation Sequencing Analysis. Iranian journal of diabetes and obesity.2023,15(2):73-80. [DOI:10.18502/ijdo.v15i2.12964]

6. Mehrabbeik A, Afkhami-Ardekani M, Namiranian N. What Do Iranian Diabetic Patients Know about Diabetes?-A Review. Iranian Journal of Diabetes and Obesity. 2024;16(4):255-61. [DOI:10.18502/ijdo.v16i4.17292]

7. Lotfi MH, Faraz MM, Namiranian N, Arab R, Dashtabadi M, Khormizi HZ. A Review About the Role of Spiritual Health in Type 2 Diabetes Mellitus People. Iranian journal of diabetes and obesity. 2024, 16(1): 59-63. [DOI:10.18502/ijdo.v16i1.15243]

8. Dadbinpour A, Dehghanian M, Mehrjardi MY. MiR-194-5p might be a Potential Biomarker for Type 2 Diabetes Mellitus. Iranian journal of diabetes and obesity. 2024, 16(3): 167-173. [DOI:10.18502/ijdo.v16i3.16324]

9. Aghaei-Zarch SM, Mehrjardi MY, Mazloumi Z, Motallebi M, Soleimani S, Tavirani MR, et al. An investigation on long non-coding RNA PVT1/miR-214/NF-κB and long non-coding RNA MALAT1/miR-9/NF-κB in individuals diagnosed with type 2 diabetes mellitus. Human Gene. 2024;39:201268. [DOI:10.1016/j.humgen.2024.201268]

10. Zahmatkesh M, Sasan H, Sefid F. Prevalence of Rs5219 and Rs5215 Polymorphisms in the Familial Type 2 Diabetic Population of Yazd Province. Iranian Journal of Diabetes and Metabolism. 2023;23(5):310-7.

11. Zarch SM, Tezerjani MD, Talebi M, Mehrjardi MY. Molecular biomarkers in diabetes mellitus (DM). Medical journal of the Islamic republic of Iran. 2020;34:28.

12. Tillin T, Hughes AD, Godsland IF, Whincup P, Forouhi NG, Welsh P, et al. Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort. Diabetes care. 2013;36(2):383-93. [DOI:10.2337/dc12-0544]

13. Dehghan Tezerjani M, Vahidi Mehrjardi MY, Kalantar SM, Dehghani M. Genetic susceptibility to transient and permanent neonatal diabetes mellitus. International Journal of Pediatrics. 2015;3(6):1073-81.

14. Salimian MR, Injinari N, Azizi R, Nikkhah H, Namiranian N. Prevalence and Impact of Thyroid Disorders on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Iranian Journal of Diabetes and Obesity. 2024;16(3):138-43. [DOI:10.18502/ijdo.v16i3.16320]

15. Foroozanfar Z, Najafipour H, Khanjani N, Bahrampour A, Ebrahimi H. The prevalence of metabolic syndrome according to different criteria and its associated factors in type 2 diabetic patients in Kerman, Iran. Iranian journal of medical sciences. 2015;40(6):522.

16. Shojima N, Yamauchi T. Progress in genetics of type 2 diabetes and diabetic complications. Journal of Diabetes Investigation. 2023;14(4):503-15. [DOI:10.1111/jdi.13970]

17. Foroozanfar Z, Ebrahimi H, Khanjani N, Bahrampour A, Najafipour H. Comparing indices of median nerve among diabetic patients with or without metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;11:S669-73. [DOI:10.1016/j.dsx.2017.04.023]

18. Vahidi A, Vahidi MY, Rezvani ME. Effect of Acute Morphine Exposure on Insulin and Blood Sugar Levels in Normal Rats.Iranian journal of diabetes and obesity.2012, 4(1): 11-14.

19. Vahidi A, Afkhami-Ardekani M, Vahidi MY, Rashidi M, Shojaoddiny-Ardekani A. Effect of Alprazolam on Serum Insulin Levels in Non-Diabetic Rats. Iranian Journal of Diabetes and Obesity. 2012;4(3):105-8.

20. Zhu P, Deng W. Single-Cell RNA-Sequencing Analyses Identify APLNR, INS-IGF2, RGCC Genes May Be Involved in the Pathogenesis of Systemic Sclerosis Skin. Clinical, Cosmetic and Investigational Dermatology. 2024:1059-69. [DOI:10.2147/CCID.S456593]

21. Felner EI, Klitz W, Ham M, Lazaro AM, Stastny P, Dupont B, et al. Genetic interaction among three genomic regions creates distinct contributions to early‐and late‐onset type 1 diabetes mellitus. Pediatric diabetes. 2005;6(4):213-20. [DOI:10.1111/j.1399-543X.2005.00132.x]

22. Sugihara S. Genetic susceptibility of childhood type 1 diabetes mellitus in Japan. Pediatr Endocrinol Rev. 2012;10(Suppl 1):62-71.

23. Bezirganoglu H, Okur N, Celik K, Tas FF, Ozbek MN. Evaluation and management of neonatal onset hyperinsulinemic hypoglycemia: a single neonatal center experience. The Journal of Maternal-Fetal & Neonatal Medicine. 2023;36(2):2272014. [DOI:10.1080/14767058.2023.2272014]

24. Fang X, Miao R, Wei J, Wu H, Tian J. Advances in multi-omics study of biomarkers of glycolipid metabolism disorder. Computational and structural biotechnology journal. 2022;20:5935-51. [DOI:10.1016/j.csbj.2022.10.030]

25. Azimi M, Paseban M, Ghareh S, Sharifi F, Bandarian F, Hasanzad M. Association of ABCC8 gene variants with response to sulfonylurea in type 2 diabetes mellitus. Journal of Diabetes & Metabolic Disorders. 2023;22(1):649-55. [DOI:10.1007/s40200-023-01189-2]

26. Ebid AH, Ehab M, Ismail A, Soror S, Mahmoud MA. The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes. Journal of Drug Assessment. 2019;8(1):115-21. [DOI:10.1080/21556660.2019.1619571]

27. Tang B, Wang Y, Jiang X, Thambisetty M, Ferrucci L, Johnell K, et al. Genetic variation in targets of antidiabetic drugs and Alzheimer disease risk: a Mendelian randomization study. Neurology. 2022;99(7):e650-9. [DOI:10.1212/WNL.0000000000200771]

28. Wallace AS, Wang D, Shin JI, Selvin E. Screening and diagnosis of prediabetes and diabetes in US children and adolescents. Pediatrics. 2020;146(3):e20200265. [DOI:10.1542/peds.2020-0265]

29. Buysschaert M, Medina JL, Buysschaert B, Bergman M. Definitions (and current controversies) of diabetes and prediabetes. Current diabetes reviews. 2016;12(1):8-13. [DOI:10.2174/1573399811666150122150233]

30. Sokhi J, Sikka R, Raina P, Kaur R, Matharoo K, Arora P, et al. Association of genetic variants in INS (rs689), INSR (rs1799816) and PP1G. G (rs1799999) with type 2 diabetes (T2D): a case-control study in three ethnic groups from North-West India. Molecular Genetics and Genomics. 2016;291:205-16. [DOI:10.1007/s00438-015-1099-2]

31. Krischer JP, Liu X, Lernmark Å, Hagopian WA, Rewers MJ, She JX, et al. Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study. Diabetes Care. 2022;45(10):2271-81. [DOI:10.2337/dc21-2612]

32. Hernández M, Nóvoa-Medina Y, Faner R, Palou E, Esquerda A, Castelblanco E, et al. Genetics: Is LADA just late onset type 1 diabetes?. Frontiers in endocrinology. 2022;13:916698. [DOI:10.3389/fendo.2022.916698]

33. Cook TW, Wilstermann AM, Mitchell JT, Arnold NE, Rajasekaran S, Bupp CP, et al. Understanding insulin in the age of precision medicine and big data: under-explored nature of genomics. Biomolecules. 2023;13(2):257. [DOI:10.3390/biom13020257]

34. Hamming KS, Soliman D, Matemisz LC, Niazi O, Lang Y, Gloyn AL, et al. Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K+ channel. Diabetes. 2009;58(10):2419-24. [DOI:10.2337/db09-0143]

35. Gerst F, Kemter E, Lorza-Gil E, Kaiser G, Fritz AK, Nano R, et al. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells. Diabetologia. 2021;64:1358-74. [DOI:10.1007/s00125-021-05435-1]

36. Tran NQ, Truong SD, Ma PT, Hoang CK, Le BH, Dinh TT, et al. Association of KCNJ11 and ABCC8 single-nucleotide polymorphisms with type 2 diabetes mellitus in a Kinh Vietnamese population. Medicine. 2022;101(46):e31653 [DOI:10.1097/MD.0000000000031653]